Skip to main content
Figure 1 | Molecular Cancer

Figure 1

From: Personalized therapies in the cancer "omics" era

Figure 1

Stepwise selection of antitumoral therapies based on individual oncogenic alterations. Analyses of oncogenic alterations in individual tumour samples using "omics" techniques should allow the identification of candidate targets for therapeutic intervention. Experimental preclinical validation of these targets is critical in order to proceed to the clinical testing of drugs that act on the selected targets.

Back to article page

Molecular Cancer

ISSN: 1476-4598